respiratory
Asthma

Popular blue puffer won’t go quietly

Changing beliefs about SABA-only reliever therapy in order to implement the new GINA guidelines on asthma management isn’t going to be easy, an expert warns. Because patients, and especially parents of paediatric patients, typically view SABAs very positively and have concerns about the ICS component of other inhaler medications. Professor Robert Horne, director of the ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic